医学
非结核分枝杆菌
抗细菌
分枝杆菌
结核分枝杆菌
滑囊炎
肺结核
肺病
乙胺丁醇
疾病
肺部感染
免疫学
微生物学
外科
病理
内科学
生物
作者
James Maloney,C. R. Gregg,David S. Stephens,Farrin A. Manian,David Rimland
标识
DOI:10.1093/clinids/9.6.1120
摘要
Mycobacterium szulgai is a scotochromogenic species that has recently been recognized as a human pathogen. Twenty-four cases of disease caused by M. szulgai in humans have been reported in the English-language literature. The clinical features of these cases were reviewed, and three additional cases (two pulmonary, one extrapulmonary) were studied. Pulmonary disease indistinguishable from that caused by Mycobacterium tuberculosis was the commonest type of infection caused by M. szulgai (18 of 27 cases). Olecranon bursitis was reported in three cases, and disseminated infection was noted in three cases occurring in immunocompromised patients. M. szulgai is more susceptible to standard antimycobacterial agents than are other nontuberculous mycobacteria, notably the Mycobacterium avium complex. Clinical improvement and cure of pulmonary disease can be anticipated when treatment includes at least three drugs effective in in vitro susceptibility tests. Surgical excision appears unnecessary in pulmonary disease but may be indicated in olecranon bursitis.
科研通智能强力驱动
Strongly Powered by AbleSci AI